David Rolfe - Wedgewood Partners Inc
Holding/activity history for Pfizer Inc. (PFE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2005 Q4 | 0 | 0.00 | Sell 100.00% | 0.20 | SEC | ||
| 2005 Q3 | 20,800 | 0.20 | Reduce 10.73% | 0.03 | $24.95 | $519,000 | SEC |
| 2005 Q2 | 23,300 | 0.32 | Reduce 48.18% | 0.30 | $27.55 | $642,000 | SEC |
| 2005 Q1 | 44,965 | 0.63 | Reduce 88.63% | 7.95 | $26.26 | $1,181,000 | SEC |
| 2004 Q4 | 395,357 | 8.97 | $30.60 | $12,097,000 | SEC | ||
| 2004 Q3 | 395,357 | 8.97 | Add 2.01% | 0.18 | $30.60 | $12,097,000 | SEC |
| 2004 Q2 | 387,570 | 8.83 | Add 15.27% | 1.17 | $34.28 | $13,285,000 | SEC |
| 2004 Q1 | 336,235 | 9.22 | Add 12.00% | 0.99 | $35.05 | $11,785,000 | SEC |
| 2003 Q4 | 300,200 | 9.63 | Add 3.72% | 0.35 | $35.33 | $10,606,000 | SEC |
| 2003 Q3 | 289,425 | 8.48 | Add 11.56% | 0.88 | $30.38 | $8,792,000 | SEC |
| 2003 Q2 | 259,443 | 8.59 | Add 3.72% | 0.31 | $34.15 | $8,859,000 | SEC |
| 2003 Q1 | 250,145 | 8.70 | Add 24.83% | 1.73 | $31.16 | $7,794,000 | SEC |
| 2002 Q4 | 200,395 | 6.65 | Reduce 7.77% | 0.60 | $30.57 | $6,126,000 | SEC |
| 2002 Q3 | 217,270 | 7.72 | Add 10.81% | 0.75 | $29.02 | $6,305,000 | SEC |
| 2002 Q2 | 196,070 | 7.32 | Add 28.61% | 1.63 | $35.00 | $6,862,000 | SEC |
| 2002 Q1 | 152,453 | 5.19 | Add 9.43% | 0.45 | $39.74 | $6,058,000 | SEC |
| 2001 Q4 | 139,313 | 4.90 | Add 2.61% | 0.12 | $39.85 | $5,552,000 | SEC |
| 2001 Q3 | 135,763 | 5.10 | Add 29.19% | 1.15 | $40.10 | $5,444,000 | SEC |
| 2001 Q2 | 105,088 | 3.09 | Add 2.80% | 0.08 | $40.04 | $4,208,000 | SEC |
| 2001 Q1 | 102,225 | 3.31 | Add 19.81% | 0.55 | $40.95 | $4,186,000 | SEC |
| 2000 Q4 | 85,322 | 2.86 | Reduce 3.18% | 0.08 | $46.00 | $3,925,000 | SEC |
| 2000 Q3 | 88,120 | 2.54 | Add 23.00% | 0.47 | $44.94 | $3,960,000 | SEC |
| 2000 Q2 | 71,645 | 2.13 | Add 5.32% | 0.11 | $48.00 | $3,439,000 | SEC |
| 2000 Q1 | 68,023 | 1.57 | $36.56 | $2,487,000 | SEC |